PAG
TNYA icon

Private Advisor Group’s Tenaya Therapeutics TNYA Stock Holding History

Private Advisor Group’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.76K Buy
+14,100
New +$10.4K ﹤0.01% 2643

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Private Advisor Group's TNYA Position: Q1 2026 in Review

Private Advisor Group opened a new position in Tenaya Therapeutics (TNYA) in Q1 2026: 14,100 shares worth $9.76K. The stake represents ﹤0.01% of the portfolio and ranks #2643 among its holdings.

103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Private Advisor Group held 14,100 shares of Tenaya Therapeutics worth $9.76K as of Q1 2026.
  • Tenaya Therapeutics was a new Private Advisor Group position in Q1 2026.
  • Tenaya Therapeutics made up ﹤0.01% of Private Advisor Group's portfolio in Q1 2026, its #2643 holding.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.